GlassScriptPhysician profile
Anthony J Mannino
NPI 1194791574
$13,944.89
in general payments reported to CMS, 2019-2025
31 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,977 · 2020: $4,505 · 2021: $4,414 · 2022: $48.53.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,000.07 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $1,563.85 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $1,486.90 | 2019-2022 | |
| Pfizer INC. | $1,315.25 | 2019-2021 | |
| Amgen INC. | $1,241.10 | 2019-2021 | |
| Allergan, INC. | $992.11 | 2019-2020 | |
| Amarin Pharma, INC. | $964.61 | 2019-2021 | |
| Glaxosmithkline, LLC. | $822.93 | 2019-2021 | |
| Lilly USA, LLC | $716.55 | 2019-2022 | |
| Abbvie INC. | $436.75 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $417.78 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $337.96 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $307.83 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $248.55 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $208.81 | 2019-2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $195.10 | 2019 | |
| Radius Health, INC. | $161.92 | 2019-2021 | |
| Astellas Pharma US INC | $150.49 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $59.97 | 2020-2021 | |
| Aytu Biopharma, INC. | $51.04 | 2019-2020 | |
| Ironwood Pharmaceuticals, INC | $41.83 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $40.41 | 2021 | |
| Sanofi-Aventis U.S. LLC | $38.47 | 2019-2020 | |
| Ibsa Pharma INC. | $37.72 | 2019 | |
| Daiichi Sankyo INC. | $24.55 | 2019 | |
| Jazz Pharmaceuticals INC. | $15.91 | 2021 | |
| Eisai INC. | $15.34 | 2021 | |
| Opko Pharmaceuticals, LLC | $14.10 | 2020 | |
| Hikma Pharmaceuticals USA | $13.58 | 2020 | |
| Sanofi Pasteur INC. | $12.56 | 2019 | |
| Supernus Pharmaceuticals, INC. | $10.85 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Mannino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.